MEDIAN Technologies Vendor's profile
Advanced medical imaging products and services for diagnosing and monitoring cancer patients
MEDIAN Technologies, an ISO 13485 certified company, develops advanced medical imaging software solutions and provides imaging services for screening, diagnosing and monitoring patients in oncology clinical routine and clinical trials.
Sinceitsinception, MEDIAN has been developingcuttingedgetools, integratedinto a clinical application portfolio, Lesion Management Solutions –LMS. LMS products are cleared as medicaldevices by the FDA, the EMA, and otherregulatory bodies and are usedfor the detection, quantification, and follow-up of cancerous or other suspicious lesions diagnosed in CT images, enabling to quantify cancer patient response to therapy.
MEDIAN leveragesitsrecognized expertise in image management for clinical routine to provideacomprehensive portfolio of product and services foroncologyclinical trials. MEDIAN offers full imaging CRO capabilities.
Based in France, MEDIAN also operates in the US through its subsidiary, MEDIAN Technologies, Inc, in the Boston area. MEDIAN is listed on Euronext Paris Alternext. ISIN Code: FR0011049824– Ticker: ALMDT.
Contact MEDIAN Technologies
To feature here : Get in touch
Agfa HealthCare Special Report Dose Management: because life is precious.
Pourquoi avoir une gestion en temps en réel de la dose d'irradiation des patients ?
BRACCO IMAGING FRANCE
Ziehm Vision RFD Hybrid Edition: Mobility and flexibility – the difference in an emergency
Olea Medical® case report on early & late MR diffusion follow-up of a stroke using CT perfusion.
Olea Medical® literature meta-analysis on CTP thresholds in acute stroke